Video Gallery

About this Video

First in human trials are a necessary and important aspect of drug development. And for some patients, they are also the best and sometimes only treatment option. However, participation comes with a high cost. We’re clinical trials viewed through a different lens—one that placed an emphasis on humanity—many if the current barriers to participation could be addressed. Linnea Olson was diagnosed with non-small cell lung cancer in April of 2005. In addition to being a vocal advocate for cancer patients, Linnea is a mother, artist, writer, friend, adventurer. She refers to herself as a terminal optimist; someone who is living (each day to the fullest) with stage 4 lung cancer.


About the Speaker

Linnea Olson

Linnea Olson

Linnea Olson was diagnosed with non-small cell lung cancer in April of 2005. In addition to being a vocal advocate for cancer patients, Linnea is a mother, artist, writer, friend, adventurer. She refers to herself as a terminal optimist; someone who is living (each day to the fullest) with stage 4 lung cancer.